Ron Baron's position in Veracyte is currently worth $27.6M. That's 0.08% of their equity portfolio (178th largest holding). The investor owns 1.16% of the outstanding Veracyte stock. The first Veracyte trade was made in Q2 2019. Since then Ron Baron bought shares eight more times and sold shares on seven occasions. The stake costed the investor $26M, netting the investor a gain of 6.2% so far.